Arm and Wrist Injuries Teach Scientists to Accept Limits

Courtesy of VistaLab TechnologiesMatthew Springer learned to take breaks and rest his hands after suffering two repetitive-motion injuries. "I ended up with two basically useless arms." In constant pain, he says, he could not type for more than a few seconds or do simple tasks like grasp a steering wheel.The injury sent him to physical therapy and he followed a prescribed regimen for a full year. He also practiced yoga, and learned to manage stress. With help from colleagues, who took over his m

Written byMignon Fogarty
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

Courtesy of VistaLab Technologies

Matthew Springer learned to take breaks and rest his hands after suffering two repetitive-motion injuries. "I ended up with two basically useless arms." In constant pain, he says, he could not type for more than a few seconds or do simple tasks like grasp a steering wheel.

The injury sent him to physical therapy and he followed a prescribed regimen for a full year. He also practiced yoga, and learned to manage stress. With help from colleagues, who took over his manual lab work for him, and voice-recognition software, he presented a body of work that helped land him an assistant professor's appointment at the University of Califor-nia, San Francisco. He still takes anti-inflammatories. He still can't hold onto a phone.

Springer took action in time to save his wrists and arms. But many researchers do not. Studies provide only sketchy details about the rate and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies